Simple Summary Human-exhaled volatile organic compounds (VOCs) can be altered by
lung cancer and become identifiable biomarkers. We used selected ion flow tube mass …

Background Breath volatile organic compounds (VOCs) have been reported as biomarkers
of lung cancer, but it is not known if biomarkers identified in one group can identify disease …

Background: Normal metabolism generates several volatile organic compounds (VOCs) that
are excreted in the breath (eg alkanes). In patients with lung cancer, induction of high-risk …

Background: Volatile organic compounds (VOCs) biomarkers in breath provide a novel,
noninvasive and quick approach to diagnosis lung cancer. The aim of the proposed study …

Background: previous studies have reported volatile organic compounds (VOCs) in the
breath as apparent biomarkers of lung cancer. We tested the hypothesis that a robust breath …

Background Breath analysis is a promising noninvasive technique that offers a wide range
of opportunities to facilitate early diagnosis of lung cancer (LC). Method Exhaled breath …

The aim of the present study was to investigate the ability of breath analysis to distinguish
lung cancer (LC) patients from patients with other respiratory diseases and healthy people …

Lung cancer (LC) is a leading cause of cancer-related morbidity and mortality globally, and
exhaled breath testing has been considered as a fast, convenient and non-invasive way to …

Lung cancer, chronic obstructive pulmonary disease (COPD) and asthma are inflammatory
diseases that have risen worldwide, posing a major public health issue, encompassing not …

In recent years, there has been an extensive search for a non-invasive screening technique
for early detection of lung cancer. Volatile organic compound (VOC) analysis in exhaled …